We are pleased to announce the start of releasing novel monoclonal antibodies against influenza and HIV-1 viral proteins. Our goal is to develop products that have unique properties, such as strain-specific; broad-recognition (pan type); neutralization, both subtype-specific and broad. Those antibodies can be used in a variety of applications, such as neutralization assay, Western Blotting, ELISA, immune-florescence, immune-precipitation, etc. We believe those products will be helpful to your work, and greatly appreciate your feedbacks. Thank you for choosing GeneImmune  products.

 For current monoclonal antibody list, click here. This list will be updated monthly, so please stay tuned.